nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—kidney cancer—liver cancer	0.298	0.512	CtDrD
Dactinomycin—sarcoma—liver cancer	0.284	0.488	CtDrD
Dactinomycin—ABCC6—Doxorubicin—liver cancer	0.131	0.39	CbGbCtD
Dactinomycin—ABCC1—Epirubicin—liver cancer	0.0726	0.217	CbGbCtD
Dactinomycin—ABCG2—Sorafenib—liver cancer	0.0426	0.127	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—liver cancer	0.0386	0.115	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—liver cancer	0.0258	0.0771	CbGbCtD
Dactinomycin—ABCB1—Sorafenib—liver cancer	0.0154	0.0458	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—liver cancer	0.00931	0.0278	CbGbCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Sorafenib—liver cancer	0.00554	0.0732	CcSEcCtD
Dactinomycin—Recall phenomenon—Sorafenib—liver cancer	0.00524	0.0693	CcSEcCtD
Dactinomycin—Radiation injury—Epirubicin—liver cancer	0.0032	0.0423	CcSEcCtD
Dactinomycin—Radiation injury—Doxorubicin—liver cancer	0.00296	0.0392	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Epirubicin—liver cancer	0.00205	0.0271	CcSEcCtD
Dactinomycin—Ascites—Sorafenib—liver cancer	0.002	0.0264	CcSEcCtD
Dactinomycin—Recall phenomenon—Epirubicin—liver cancer	0.00194	0.0256	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Epirubicin—liver cancer	0.00194	0.0256	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Doxorubicin—liver cancer	0.00189	0.025	CcSEcCtD
Dactinomycin—Recall phenomenon—Doxorubicin—liver cancer	0.00179	0.0237	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Doxorubicin—liver cancer	0.00179	0.0237	CcSEcCtD
Dactinomycin—Folliculitis—Sorafenib—liver cancer	0.00145	0.0191	CcSEcCtD
Dactinomycin—Proctitis—Epirubicin—liver cancer	0.00138	0.0182	CcSEcCtD
Dactinomycin—Proctitis—Doxorubicin—liver cancer	0.00127	0.0168	CcSEcCtD
Dactinomycin—Multi-organ failure—Epirubicin—liver cancer	0.00103	0.0136	CcSEcCtD
Dactinomycin—Hypocalcaemia—Sorafenib—liver cancer	0.000993	0.0131	CcSEcCtD
Dactinomycin—Multi-organ failure—Doxorubicin—liver cancer	0.000954	0.0126	CcSEcCtD
Dactinomycin—Mouth ulceration—Sorafenib—liver cancer	0.000822	0.0109	CcSEcCtD
Dactinomycin—Ascites—Epirubicin—liver cancer	0.000739	0.00977	CcSEcCtD
Dactinomycin—Hepatic failure—Sorafenib—liver cancer	0.000734	0.0097	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Epirubicin—liver cancer	0.000728	0.00962	CcSEcCtD
Dactinomycin—Myelosuppression—Epirubicin—liver cancer	0.000716	0.00947	CcSEcCtD
Dactinomycin—Ascites—Doxorubicin—liver cancer	0.000684	0.00904	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Doxorubicin—liver cancer	0.000673	0.0089	CcSEcCtD
Dactinomycin—Myelosuppression—Doxorubicin—liver cancer	0.000663	0.00876	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.000594	0.00785	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.000594	0.00785	CcSEcCtD
Dactinomycin—Dysphagia—Sorafenib—liver cancer	0.00057	0.00754	CcSEcCtD
Dactinomycin—Febrile neutropenia—Epirubicin—liver cancer	0.000558	0.00738	CcSEcCtD
Dactinomycin—Eruption—Epirubicin—liver cancer	0.000546	0.00722	CcSEcCtD
Dactinomycin—Folliculitis—Epirubicin—liver cancer	0.000534	0.00706	CcSEcCtD
Dactinomycin—Neutropenia—Sorafenib—liver cancer	0.000533	0.00705	CcSEcCtD
Dactinomycin—Febrile neutropenia—Doxorubicin—liver cancer	0.000517	0.00683	CcSEcCtD
Dactinomycin—Pneumonia—Sorafenib—liver cancer	0.000511	0.00676	CcSEcCtD
Dactinomycin—Eruption—Doxorubicin—liver cancer	0.000505	0.00668	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000504	0.00666	CcSEcCtD
Dactinomycin—Stomatitis—Sorafenib—liver cancer	0.000496	0.00655	CcSEcCtD
Dactinomycin—Folliculitis—Doxorubicin—liver cancer	0.000494	0.00654	CcSEcCtD
Dactinomycin—Hepatomegaly—Epirubicin—liver cancer	0.000475	0.00627	CcSEcCtD
Dactinomycin—Hepatomegaly—Doxorubicin—liver cancer	0.000439	0.0058	CcSEcCtD
Dactinomycin—Erythema multiforme—Sorafenib—liver cancer	0.000432	0.0057	CcSEcCtD
Dactinomycin—Necrosis—Epirubicin—liver cancer	0.000428	0.00566	CcSEcCtD
Dactinomycin—Flushing—Sorafenib—liver cancer	0.000424	0.0056	CcSEcCtD
Dactinomycin—Alopecia—Sorafenib—liver cancer	0.000403	0.00533	CcSEcCtD
Dactinomycin—Erythema—Sorafenib—liver cancer	0.000397	0.00525	CcSEcCtD
Dactinomycin—Necrosis—Doxorubicin—liver cancer	0.000396	0.00523	CcSEcCtD
Dactinomycin—Extravasation—Epirubicin—liver cancer	0.000385	0.00509	CcSEcCtD
Dactinomycin—Anaemia—Sorafenib—liver cancer	0.000367	0.00485	CcSEcCtD
Dactinomycin—Hypocalcaemia—Epirubicin—liver cancer	0.000367	0.00485	CcSEcCtD
Dactinomycin—Extravasation—Doxorubicin—liver cancer	0.000356	0.00471	CcSEcCtD
Dactinomycin—Leukopenia—Sorafenib—liver cancer	0.000356	0.0047	CcSEcCtD
Dactinomycin—Ulcer—Epirubicin—liver cancer	0.000355	0.00469	CcSEcCtD
Dactinomycin—Hypocalcaemia—Doxorubicin—liver cancer	0.00034	0.00449	CcSEcCtD
Dactinomycin—Myalgia—Sorafenib—liver cancer	0.000338	0.00447	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—liver cancer	0.000329	0.00434	CcSEcCtD
Dactinomycin—Infection—Sorafenib—liver cancer	0.000322	0.00426	CcSEcCtD
Dactinomycin—Thrombocytopenia—Sorafenib—liver cancer	0.000318	0.0042	CcSEcCtD
Dactinomycin—Aplastic anaemia—Epirubicin—liver cancer	0.000315	0.00417	CcSEcCtD
Dactinomycin—Anorexia—Sorafenib—liver cancer	0.000309	0.00409	CcSEcCtD
Dactinomycin—Oesophagitis—Epirubicin—liver cancer	0.000307	0.00406	CcSEcCtD
Dactinomycin—Mouth ulceration—Epirubicin—liver cancer	0.000304	0.00401	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000295	0.00391	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—liver cancer	0.000292	0.00386	CcSEcCtD
Dactinomycin—Sepsis—Epirubicin—liver cancer	0.000292	0.00385	CcSEcCtD
Dactinomycin—Oesophagitis—Doxorubicin—liver cancer	0.000284	0.00375	CcSEcCtD
Dactinomycin—Phlebitis—Epirubicin—liver cancer	0.000283	0.00374	CcSEcCtD
Dactinomycin—Decreased appetite—Sorafenib—liver cancer	0.000282	0.00373	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—liver cancer	0.000281	0.00371	CcSEcCtD
Dactinomycin—Fatigue—Sorafenib—liver cancer	0.00028	0.0037	CcSEcCtD
Dactinomycin—Pain—Sorafenib—liver cancer	0.000277	0.00367	CcSEcCtD
Dactinomycin—Hepatic failure—Epirubicin—liver cancer	0.000271	0.00359	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—liver cancer	0.00027	0.00357	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Sorafenib—liver cancer	0.000265	0.00351	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—liver cancer	0.000262	0.00346	CcSEcCtD
Dactinomycin—Abdominal pain—Sorafenib—liver cancer	0.000256	0.00339	CcSEcCtD
Dactinomycin—Body temperature increased—Sorafenib—liver cancer	0.000256	0.00339	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—liver cancer	0.000251	0.00332	CcSEcCtD
Dactinomycin—Lethargy—Epirubicin—liver cancer	0.000249	0.00329	CcSEcCtD
Dactinomycin—Hypersensitivity—Sorafenib—liver cancer	0.000239	0.00316	CcSEcCtD
Dactinomycin—Asthenia—Sorafenib—liver cancer	0.000233	0.00308	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—liver cancer	0.00023	0.00304	CcSEcCtD
Dactinomycin—Liver function test abnormal—Epirubicin—liver cancer	0.000225	0.00298	CcSEcCtD
Dactinomycin—Diarrhoea—Sorafenib—liver cancer	0.000222	0.00293	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00022	0.0029	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00022	0.0029	CcSEcCtD
Dactinomycin—Dysphagia—Epirubicin—liver cancer	0.000211	0.00279	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—liver cancer	0.000208	0.00275	CcSEcCtD
Dactinomycin—Vomiting—Sorafenib—liver cancer	0.000206	0.00273	CcSEcCtD
Dactinomycin—Rash—Sorafenib—liver cancer	0.000204	0.0027	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000203	0.00269	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000203	0.00269	CcSEcCtD
Dactinomycin—Pancytopenia—Epirubicin—liver cancer	0.0002	0.00265	CcSEcCtD
Dactinomycin—Neutropenia—Epirubicin—liver cancer	0.000197	0.0026	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—liver cancer	0.000195	0.00258	CcSEcCtD
Dactinomycin—Nausea—Sorafenib—liver cancer	0.000193	0.00255	CcSEcCtD
Dactinomycin—Pneumonia—Epirubicin—liver cancer	0.000189	0.0025	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000186	0.00246	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—liver cancer	0.000185	0.00245	CcSEcCtD
Dactinomycin—Stomatitis—Epirubicin—liver cancer	0.000183	0.00242	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—liver cancer	0.000182	0.00241	CcSEcCtD
Dactinomycin—Agranulocytosis—Epirubicin—liver cancer	0.000175	0.00232	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—liver cancer	0.000175	0.00231	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000172	0.00228	CcSEcCtD
Dactinomycin—Stomatitis—Doxorubicin—liver cancer	0.000169	0.00224	CcSEcCtD
Dactinomycin—Hepatitis—Epirubicin—liver cancer	0.000169	0.00223	CcSEcCtD
Dactinomycin—Pharyngitis—Epirubicin—liver cancer	0.000167	0.00221	CcSEcCtD
Dactinomycin—Agranulocytosis—Doxorubicin—liver cancer	0.000162	0.00214	CcSEcCtD
Dactinomycin—Erythema multiforme—Epirubicin—liver cancer	0.000159	0.00211	CcSEcCtD
Dactinomycin—Flushing—Epirubicin—liver cancer	0.000157	0.00207	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—liver cancer	0.000156	0.00206	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—liver cancer	0.000155	0.00205	CcSEcCtD
Dactinomycin—Chills—Epirubicin—liver cancer	0.000151	0.002	CcSEcCtD
Dactinomycin—Alopecia—Epirubicin—liver cancer	0.000149	0.00197	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—liver cancer	0.000148	0.00195	CcSEcCtD
Dactinomycin—Erythema—Epirubicin—liver cancer	0.000147	0.00194	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—liver cancer	0.000145	0.00191	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—liver cancer	0.00014	0.00185	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—liver cancer	0.000138	0.00182	CcSEcCtD
Dactinomycin—Ill-defined disorder—Epirubicin—liver cancer	0.000136	0.0018	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—liver cancer	0.000136	0.0018	CcSEcCtD
Dactinomycin—Anaemia—Epirubicin—liver cancer	0.000136	0.00179	CcSEcCtD
Dactinomycin—Malaise—Epirubicin—liver cancer	0.000132	0.00175	CcSEcCtD
Dactinomycin—Leukopenia—Epirubicin—liver cancer	0.000131	0.00174	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—liver cancer	0.000126	0.00167	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—liver cancer	0.000126	0.00166	CcSEcCtD
Dactinomycin—Myalgia—Epirubicin—liver cancer	0.000125	0.00165	CcSEcCtD
Dactinomycin—Discomfort—Epirubicin—liver cancer	0.000124	0.00163	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—liver cancer	0.000123	0.00162	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—liver cancer	0.000122	0.00161	CcSEcCtD
Dactinomycin—Oedema—Epirubicin—liver cancer	0.00012	0.00158	CcSEcCtD
Dactinomycin—Infection—Epirubicin—liver cancer	0.000119	0.00157	CcSEcCtD
Dactinomycin—Thrombocytopenia—Epirubicin—liver cancer	0.000117	0.00155	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—liver cancer	0.000116	0.00153	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—liver cancer	0.000114	0.00151	CcSEcCtD
Dactinomycin—Anorexia—Epirubicin—liver cancer	0.000114	0.00151	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—liver cancer	0.000111	0.00147	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—liver cancer	0.00011	0.00146	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000109	0.00144	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—liver cancer	0.000109	0.00144	CcSEcCtD
Dactinomycin—Anorexia—Doxorubicin—liver cancer	0.000106	0.0014	CcSEcCtD
Dactinomycin—Decreased appetite—Epirubicin—liver cancer	0.000104	0.00138	CcSEcCtD
Dactinomycin—Fatigue—Epirubicin—liver cancer	0.000103	0.00137	CcSEcCtD
Dactinomycin—Pain—Epirubicin—liver cancer	0.000102	0.00135	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000101	0.00134	CcSEcCtD
Dactinomycin—Feeling abnormal—Epirubicin—liver cancer	9.88e-05	0.00131	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Epirubicin—liver cancer	9.8e-05	0.0013	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—liver cancer	9.64e-05	0.00127	CcSEcCtD
Dactinomycin—Fatigue—Doxorubicin—liver cancer	9.56e-05	0.00126	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—liver cancer	9.48e-05	0.00125	CcSEcCtD
Dactinomycin—Body temperature increased—Epirubicin—liver cancer	9.47e-05	0.00125	CcSEcCtD
Dactinomycin—Abdominal pain—Epirubicin—liver cancer	9.47e-05	0.00125	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—liver cancer	9.14e-05	0.00121	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—liver cancer	9.07e-05	0.0012	CcSEcCtD
Dactinomycin—Hypersensitivity—Epirubicin—liver cancer	8.83e-05	0.00117	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—liver cancer	8.77e-05	0.00116	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—liver cancer	8.77e-05	0.00116	CcSEcCtD
Dactinomycin—Asthenia—Epirubicin—liver cancer	8.6e-05	0.00114	CcSEcCtD
Dactinomycin—Diarrhoea—Epirubicin—liver cancer	8.2e-05	0.00108	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—liver cancer	8.17e-05	0.00108	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—liver cancer	7.96e-05	0.00105	CcSEcCtD
Dactinomycin—Vomiting—Epirubicin—liver cancer	7.62e-05	0.00101	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—liver cancer	7.59e-05	0.001	CcSEcCtD
Dactinomycin—Rash—Epirubicin—liver cancer	7.56e-05	0.000999	CcSEcCtD
Dactinomycin—Nausea—Epirubicin—liver cancer	7.12e-05	0.000941	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—liver cancer	7.05e-05	0.000932	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—liver cancer	6.99e-05	0.000924	CcSEcCtD
Dactinomycin—Nausea—Doxorubicin—liver cancer	6.59e-05	0.000871	CcSEcCtD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—MYO5B—liver cancer	5.03e-05	0.00706	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL12A—liver cancer	4.86e-05	0.00683	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—MYO5B—liver cancer	4.42e-05	0.00622	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC9C1—liver cancer	4.42e-05	0.00622	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—CYCS—liver cancer	4.28e-05	0.00601	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—liver cancer	4.25e-05	0.00597	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—TERT—liver cancer	4.2e-05	0.0059	CbGpPWpGaD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—liver cancer	3.84e-05	0.00539	CbGpPWpGaD
Dactinomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	3.8e-05	0.00534	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	3.77e-05	0.00529	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—HMOX1—liver cancer	3.72e-05	0.00522	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—liver cancer	3.6e-05	0.00505	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC11A2—liver cancer	3.56e-05	0.005	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	3.48e-05	0.00489	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC40A1—liver cancer	3.4e-05	0.00477	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—APCS—liver cancer	3.31e-05	0.00465	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ATP7B—liver cancer	3.26e-05	0.00458	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ANXA2—liver cancer	3.26e-05	0.00458	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	3.23e-05	0.00454	CbGpPWpGaD
Dactinomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	3.14e-05	0.00441	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—NR1H4—liver cancer	3.08e-05	0.00433	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	3.08e-05	0.00432	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL12B—liver cancer	3.05e-05	0.00429	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—PPARA—liver cancer	3e-05	0.00422	CbGpPWpGaD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—TP53—liver cancer	2.78e-05	0.00391	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	2.77e-05	0.00388	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC11A2—liver cancer	2.57e-05	0.00362	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	2.47e-05	0.00347	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC40A1—liver cancer	2.46e-05	0.00345	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	2.43e-05	0.00341	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—JUN—liver cancer	2.42e-05	0.0034	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	2.39e-05	0.00336	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	2.39e-05	0.00336	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ATP7B—liver cancer	2.35e-05	0.00331	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ANXA2—liver cancer	2.35e-05	0.00331	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	2.34e-05	0.00329	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	2.34e-05	0.00328	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	2.27e-05	0.00319	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC11A2—liver cancer	2.26e-05	0.00318	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—ALB—liver cancer	2.23e-05	0.00314	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—NR1H4—liver cancer	2.23e-05	0.00313	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC40A1—liver cancer	2.16e-05	0.00304	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—liver cancer	2.12e-05	0.00297	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ANXA2—liver cancer	2.07e-05	0.00291	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ATP7B—liver cancer	2.07e-05	0.00291	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—RAF1—liver cancer	2.02e-05	0.00284	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—NR1H4—liver cancer	1.96e-05	0.00275	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	1.82e-05	0.00255	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	1.79e-05	0.00251	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—UGDH—liver cancer	1.78e-05	0.00251	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	1.78e-05	0.0025	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	1.75e-05	0.00245	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—EPT1—liver cancer	1.68e-05	0.00236	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	1.66e-05	0.00234	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—ALB—liver cancer	1.61e-05	0.00227	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—TAT—liver cancer	1.59e-05	0.00223	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—UGDH—liver cancer	1.57e-05	0.00221	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—CYCS—liver cancer	1.57e-05	0.00221	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	1.56e-05	0.0022	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—EPT1—liver cancer	1.48e-05	0.00207	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—TAT—liver cancer	1.4e-05	0.00197	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—HMOX1—liver cancer	1.36e-05	0.00192	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—AKT1—liver cancer	1.35e-05	0.0019	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	1.34e-05	0.00188	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	1.31e-05	0.00184	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—LTF—liver cancer	1.29e-05	0.00181	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	1.22e-05	0.00172	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	1.17e-05	0.00165	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.17e-05	0.00164	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	1.17e-05	0.00164	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CASP3—liver cancer	1.17e-05	0.00164	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL2—liver cancer	1.17e-05	0.00164	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	1.14e-05	0.00161	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—CYCS—liver cancer	1.13e-05	0.00159	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	1.12e-05	0.00157	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	1.12e-05	0.00157	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—PPARA—liver cancer	1.1e-05	0.00155	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CPT1B—liver cancer	1.08e-05	0.00152	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GLUL—liver cancer	1.08e-05	0.00152	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	1.06e-05	0.00149	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—NR1H4—liver cancer	1.04e-05	0.00146	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTA3—liver cancer	1.03e-05	0.00144	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	1e-05	0.00141	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—CYCS—liver cancer	9.98e-06	0.0014	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ALDOB—liver cancer	9.98e-06	0.0014	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—VEGFA—liver cancer	9.91e-06	0.00139	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—HMOX1—liver cancer	9.86e-06	0.00139	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GLUL—liver cancer	9.51e-06	0.00134	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CPT1B—liver cancer	9.51e-06	0.00134	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTA4—liver cancer	9.37e-06	0.00132	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—NR1H4—liver cancer	9.17e-06	0.00129	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.16e-06	0.00129	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTA2—liver cancer	9.14e-06	0.00128	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—TGFB1—liver cancer	9.09e-06	0.00128	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTA3—liver cancer	9.02e-06	0.00127	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	8.82e-06	0.00124	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTA1—liver cancer	8.81e-06	0.00124	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—NAT2—liver cancer	8.72e-06	0.00122	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—HMOX1—liver cancer	8.68e-06	0.00122	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	8.65e-06	0.00122	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—TNF—liver cancer	8.49e-06	0.00119	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—UGDH—liver cancer	8.49e-06	0.00119	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.38e-06	0.00118	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ALDOB—liver cancer	8.36e-06	0.00117	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTA4—liver cancer	8.25e-06	0.00116	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ALB—liver cancer	8.2e-06	0.00115	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	8.18e-06	0.00115	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTA2—liver cancer	8.04e-06	0.00113	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—EPT1—liver cancer	7.98e-06	0.00112	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CRABP1—liver cancer	7.97e-06	0.00112	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—PPARA—liver cancer	7.97e-06	0.00112	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ADAM17—liver cancer	7.89e-06	0.00111	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTA1—liver cancer	7.76e-06	0.00109	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—NAT2—liver cancer	7.67e-06	0.00108	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—TAT—liver cancer	7.57e-06	0.00106	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PSMA4—liver cancer	7.42e-06	0.00104	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PSMD10—liver cancer	7.42e-06	0.00104	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—RAF1—liver cancer	7.41e-06	0.00104	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ALDOB—liver cancer	7.35e-06	0.00103	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	7.3e-06	0.00103	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—GOT2—liver cancer	7.21e-06	0.00101	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.18e-06	0.00101	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CRABP1—liver cancer	7.01e-06	0.000985	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—PPARA—liver cancer	7.01e-06	0.000985	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—HPGDS—liver cancer	6.97e-06	0.000979	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.93e-06	0.000973	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	6.42e-06	0.000902	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.31e-06	0.000886	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.23e-06	0.000875	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—GOT1—liver cancer	6.23e-06	0.000875	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PSMD10—liver cancer	6.21e-06	0.000872	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PSMA4—liver cancer	6.21e-06	0.000872	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—HPGDS—liver cancer	6.13e-06	0.000861	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GOT2—liver cancer	6.04e-06	0.000849	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ALB—liver cancer	5.92e-06	0.000832	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	5.88e-06	0.000826	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	5.76e-06	0.00081	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PRKCE—liver cancer	5.74e-06	0.000807	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP2E1—liver cancer	5.68e-06	0.000798	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	5.61e-06	0.000788	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	5.6e-06	0.000786	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	5.55e-06	0.00078	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.5e-06	0.000773	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PSMA4—liver cancer	5.46e-06	0.000768	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PSMD10—liver cancer	5.46e-06	0.000768	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	5.43e-06	0.000762	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	5.4e-06	0.000758	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	5.36e-06	0.000752	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GOT2—liver cancer	5.32e-06	0.000747	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYCS—liver cancer	5.31e-06	0.000747	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	5.3e-06	0.000744	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GGT1—liver cancer	5.21e-06	0.000733	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GOT1—liver cancer	5.21e-06	0.000733	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	5.21e-06	0.000732	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GLUL—liver cancer	5.14e-06	0.000723	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CPT1B—liver cancer	5.14e-06	0.000723	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—H2AFX—liver cancer	5.01e-06	0.000704	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP2E1—liver cancer	5e-06	0.000702	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—NR1H4—liver cancer	4.96e-06	0.000697	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	4.89e-06	0.000687	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTA3—liver cancer	4.88e-06	0.000685	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	4.71e-06	0.000662	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	4.69e-06	0.000659	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTP1—liver cancer	4.68e-06	0.000658	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYCS—liver cancer	4.68e-06	0.000657	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—HMOX1—liver cancer	4.62e-06	0.000649	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GOT1—liver cancer	4.59e-06	0.000645	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GGT1—liver cancer	4.59e-06	0.000645	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MTHFR—liver cancer	4.54e-06	0.000638	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TERT—liver cancer	4.53e-06	0.000636	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	4.5e-06	0.000632	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	4.49e-06	0.000631	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTA4—liver cancer	4.46e-06	0.000627	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTA2—liver cancer	4.35e-06	0.000611	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTM1—liver cancer	4.3e-06	0.000605	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTA1—liver cancer	4.19e-06	0.000589	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.19e-06	0.000589	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.16e-06	0.000584	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—NAT2—liver cancer	4.15e-06	0.000582	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTP1—liver cancer	4.12e-06	0.000579	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP1A1—liver cancer	4.08e-06	0.000573	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—HMOX1—liver cancer	4.06e-06	0.000571	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ALDOB—liver cancer	3.98e-06	0.000558	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.82e-06	0.000537	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—APC—liver cancer	3.82e-06	0.000536	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—MTHFR—liver cancer	3.8e-06	0.000534	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CRABP1—liver cancer	3.79e-06	0.000533	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	3.79e-06	0.000533	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTM1—liver cancer	3.79e-06	0.000532	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PPARA—liver cancer	3.73e-06	0.000524	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	3.69e-06	0.000519	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP1A1—liver cancer	3.59e-06	0.000504	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—BRAF—liver cancer	3.59e-06	0.000504	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CD—liver cancer	3.36e-06	0.000471	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.35e-06	0.000471	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—MTHFR—liver cancer	3.35e-06	0.00047	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SERPINE1—liver cancer	3.32e-06	0.000466	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—HPGDS—liver cancer	3.31e-06	0.000466	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PPARA—liver cancer	3.28e-06	0.000461	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CG—liver cancer	3.2e-06	0.000449	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.12e-06	0.000438	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PPARG—liver cancer	3.08e-06	0.000433	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—RAF1—liver cancer	3e-06	0.000421	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PSMA4—liver cancer	2.95e-06	0.000415	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PSMD10—liver cancer	2.95e-06	0.000415	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MTOR—liver cancer	2.92e-06	0.000411	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CB—liver cancer	2.92e-06	0.000411	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GOT2—liver cancer	2.87e-06	0.000404	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.82e-06	0.000396	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CG—liver cancer	2.81e-06	0.000395	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CD—liver cancer	2.81e-06	0.000395	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ALB—liver cancer	2.77e-06	0.00039	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN1B—liver cancer	2.74e-06	0.000386	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PPARG—liver cancer	2.71e-06	0.000381	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP2E1—liver cancer	2.7e-06	0.00038	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CTNNB1—liver cancer	2.59e-06	0.000364	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.55e-06	0.000358	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN1A—liver cancer	2.53e-06	0.000356	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYCS—liver cancer	2.53e-06	0.000355	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GOT1—liver cancer	2.48e-06	0.000349	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GGT1—liver cancer	2.48e-06	0.000349	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CD—liver cancer	2.47e-06	0.000347	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CB—liver cancer	2.45e-06	0.000344	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ALB—liver cancer	2.44e-06	0.000343	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—STAT3—liver cancer	2.26e-06	0.000317	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTP1—liver cancer	2.23e-06	0.000313	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—HMOX1—liver cancer	2.2e-06	0.000309	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CB—liver cancer	2.16e-06	0.000303	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MYC—liver cancer	2.1e-06	0.000295	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TGFB1—liver cancer	2.09e-06	0.000294	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTM1—liver cancer	2.05e-06	0.000288	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP1A1—liver cancer	1.94e-06	0.000273	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—KRAS—liver cancer	1.94e-06	0.000273	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—MTHFR—liver cancer	1.81e-06	0.000254	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CA—liver cancer	1.78e-06	0.00025	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PPARA—liver cancer	1.78e-06	0.000249	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HRAS—liver cancer	1.65e-06	0.000232	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—IL6—liver cancer	1.58e-06	0.000222	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CG—liver cancer	1.52e-06	0.000214	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CA—liver cancer	1.49e-06	0.00021	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PPARG—liver cancer	1.47e-06	0.000206	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—AKT1—liver cancer	1.46e-06	0.000205	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CD—liver cancer	1.34e-06	0.000188	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ALB—liver cancer	1.32e-06	0.000185	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CA—liver cancer	1.31e-06	0.000185	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—AKT1—liver cancer	1.22e-06	0.000171	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CB—liver cancer	1.17e-06	0.000164	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—AKT1—liver cancer	1.07e-06	0.000151	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CA—liver cancer	7.1e-07	9.98e-05	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—AKT1—liver cancer	5.8e-07	8.15e-05	CbGpPWpGaD
